Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyskinesia, Medication-induced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06997198
What this trial is testing

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
University Hospitals Cleveland Medical Center 25
Large-scale testing (Phase 3)WithdrawnNCT03254186
What this trial is testing

Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Emory University
Large-scale testing (Phase 3)Study completedNCT02198794
What this trial is testing

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 343
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Large-scale testing (Phase 3)Study completedNCT02195700
What this trial is testing

Aim to Reduce Movements in Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Auspex Pharmaceuticals, Inc. 117
Early research (Phase 1)Study completedNCT05238701
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects

Who this might be right for
Huntington DiseaseTardive Dyskinesia
Luye Pharma Group Ltd. 104
Post-approval studies (Phase 4)UnknownNCT00468533
What this trial is testing

The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial

Who this might be right for
Schizophrenia, Tardive Dyskinesia, Metabolic Syndrome
Yu-Li Hospital 50
Large-scale testing (Phase 3)Study completedNCT00291213
What this trial is testing

Levetiracetam Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Yale University 50
Testing effectiveness (Phase 2)Ended earlyNCT00693472
What this trial is testing

Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)

Who this might be right for
Akathisia, Drug-InducedAntipsychotic AgentsMovement Disorders
Merck Sharp & Dohme LLC 46
Large-scale testing (Phase 3)Study completedNCT02274558
What this trial is testing

NBI-98854 for the Treatment of Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 234
Early research (Phase 1)Study completedNCT06474650
What this trial is testing

Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets

Who this might be right for
Huntington DiseaseTardive Dyskinesia
Luye Pharma Group Ltd. 16
Large-scale testing (Phase 3)Study completedNCT00190008
What this trial is testing

Piracetam for Treatment Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Beersheva Mental Health Center 40
Testing effectiveness (Phase 2)Study completedNCT02657681
What this trial is testing

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Who this might be right for
Dyskinesia, Medication-InducedParkinson's Disease
Fundación de investigación HM 50
Testing effectiveness (Phase 2)Study completedNCT01173731
What this trial is testing

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedLevodopa
Novartis Pharmaceuticals 66
Testing effectiveness (Phase 2)UnknownNCT00331669
What this trial is testing

Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia

Who this might be right for
DystoniaMovement Disorder
Charite University, Berlin, Germany 24
Not applicableStudy completedNCT04064294
What this trial is testing

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-Induced
VA Office of Research and Development 93
Early research (Phase 1)Study completedNCT00255879
What this trial is testing

Movement Disorders Caused by Antipsychotic Drugs in Older Patients

Who this might be right for
Dyskinesia, Drug-Induced
University of California, San Diego 250
Not applicableStudy completedNCT00065286
What this trial is testing

Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation

Who this might be right for
Akathisia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not applicableActive Not RecruitingNCT02252380
What this trial is testing

ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders

Who this might be right for
Movement DisordersEssential TremorHolmes Tremor+6 more
InSightec 10
Not applicableStudy completedNCT01391390
What this trial is testing

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

Who this might be right for
Tardive Dyskinesia
Beijing HuiLongGuan Hospital 120
Next Page